Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a peripheral vasodilator. Its exact mechanism of action is not fully understood but is thought to involve direct relaxation of vascular smooth muscle.
## Primary Indications
* Treatment of peripheral vascular disease, such as intermittent claudication, due to vasospasm.
* Management of cerebrovascular insufficiency.
## Adult Dosing
* **Intermittent Claudication/Peripheral Vascular Disease:** The typical dose is 10-20 mg by mouth 3 to 4 times daily.
* **Cerebrovascular Insufficiency:** The typical dose is 20 mg by mouth 3 to 4 times daily.
* **Maximum Dose:** Not explicitly defined, but doses exceeding 20 mg four times daily are generally not recommended.
## Pediatric Dosing
There is no established pediatric dose for isoxsuprine hydrochloride. Its use in children is generally not recommended.
## Dose Adjustments
No specific dose adjustments are routinely recommended for hepatic or renal impairment. However, caution may be warranted in patients with severe impairment.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Administration by injection in patients with congenital heart disease.
## Adverse Effects
Common adverse effects include:
* Nausea
* Vomiting
* Dizziness
* Weakness
* Hypotension (especially with rapid intravenous administration, though oral administration is preferred)
* Gastrointestinal upset
* Rash
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* **Other Vasodilators:** Concomitant use with other vasodilators may increase the risk of hypotension.
## Monitoring
* Blood pressure
* Symptoms of peripheral vascular disease (e.g., walking distance, pain)
* Signs of adverse effects
## Clinical Pearls
* Oral administration is the preferred route. Intravenous administration should be used with extreme caution due to the risk of severe hypotension and arrhythmias, particularly in patients with congenital heart disease.
* Efficacy in peripheral vascular disease is controversial, and many guidelines do not recommend its routine use.
* Patient education regarding potential side effects, especially dizziness and weakness, is important.
***
**Disclaimer:** This information is intended for clinical use and does not replace comprehensive drug compendia. Always verify current prescribing information, including specific dosing, indications, contraindications, warnings, precautions, and potential drug interactions, with official resources before administering any medication.